Hypotension Prediction Index for Blood Pressure Management
NCT ID: NCT03610165
Last Updated: 2021-05-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
214 participants
INTERVENTIONAL
2018-07-12
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension.
Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypotension Prediction Index Study (HPI Study)
NCT03805217
HPI (Hypotension Prediction Index) Care Trial
NCT05083403
"Hypotension Probability Indicator" in TAVI/MitraClip for Hypotension Management
NCT06347211
The EU Hyprotect Registry
NCT04972266
SMART TRENDS Study
NCT05957406
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
AIMS To determine whether use of Acumen HPI software to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension.
PRIMARY HYPOTHESIS Our primary hypothesis is that use of the Acumen HPI software guidance reduces TWA intraoperative hypotension below a threshold of 65 mmHg.
Specifically, we will compare the amount of intraoperative hypotension below mean-arterial pressure (MAP) threshold of 65 mmHg, in patients randomized to invasive arterial pressure monitoring vs. invasive arterial pressure monitoring with Acumen Hypotension Prediction Index software. In both cases, clinicians will strive to keep MAP above 65 mmHg to the extent practical.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arterial line - Control
Arterial line waveform and pressure
Control
Arterial waveform and pressures
Acumen HPI-enabled EV1000 screen
Arterial line waveform and pressure + HPI alert from EV1000 monitor
Acumen HPI-enabled EV1000 screen
Acumen HPI-enabled EV1000 screen.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acumen HPI-enabled EV1000 screen
Acumen HPI-enabled EV1000 screen.
Control
Arterial waveform and pressures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥45 years
* ASA Physical Status 3 or 4
* Moderate- or high-risk surgery (for example, orthopedic, spine, urology, and general surgery)
* Planned invasive blood pressure monitoring
* General anesthesia
* Surgery duration expected to last \>2 hours
* Planned overnight hospitalization
Exclusion Criteria
* Pregnancy
* Emergency surgery
* Known clinically important intracardiac shunts
* Known aortic stenosis with valve area ≤ 1.5 cm2
* Known moderate to severe aortic regurgitation
* Known moderate to severe mitral regurgitation
* Known moderate to severe mitral stenosis
* Patient or surgical procedure type known as an SVV limitation16 (e.g. tidal volume \<8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate (HR/RR) ratio \<3.6)
* Current persistent atrial fibrillation
* Congestive heart failure with ejection fraction \<35%
* Neurosurgery
* Emergent or cardiovascular surgical procedure
* Patient who is confirmed to be pregnant
* Refusal of patient or authorized representative to sign consent
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kamal Maheshwari, MD MPH
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kamal Maheshwari, MD, MPH
Role: STUDY_DIRECTOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Maheshwari K, Shimada T, Fang J, Ince I, Mascha EJ, Turan A, Kurz A, Sessler DI. Hypotension Prediction Index software for management of hypotension during moderate- to high-risk noncardiac surgery: protocol for a randomized trial. Trials. 2019 May 3;20(1):255. doi: 10.1186/s13063-019-3329-0.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-557
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.